9 Meters Biopharma to execute 1-for-20 reverse stock split
seekingalpha.com
news
2022-10-17 12:20:22

Tempura/iStock via Getty Images Clinical-stage company 9 Meters Biopharma (NASDAQ:NMTR) is set to execute a 1-for-20 reverse stock split, effective Oct. 17 5:00 p.m. ET. The company will begin trading on a split-adjusted basis from Oct. 18 under the existing ticker symbol NMTR. The move, which reduces the number of issued and outstanding common shares from 259,107,380 to ~12,955,369, is likely to bring the company into compliance with Nasdaq's minimum bid price requirement. The reverse stock split was previously approved by the company's shareholders at the Jun.
